Pulsenmore Expands U.S. Presence with New Home Ultrasound Partnership

summarizeSummary

Pulsenmore Ltd. announced a new commercial engagement with TLC Perinatal PA, a maternal-fetal medicine practice in Maryland, to integrate its home ultrasound services into their care model, marking continued U.S. expansion.

check_boxKey Events

• Secures New U.S. Commercial Engagement

  Pulsenmore entered a services agreement with TLC Perinatal PA in Maryland to integrate its Early Screening (ES) home ultrasound services.

• Expands U.S. Market Rollout

  This marks another step in the company's growing U.S. commercial operations, following its initial engagement earlier this month on 2026-02-02 and recent Nasdaq registration on 2026-01-27.

• Validates Hybrid Care Model

  The partnership will allow patients to perform ultrasound scans at home as part of a physician-directed hybrid care pathway, enhancing access and convenience.

auto_awesomeAnalysis

This filing highlights Pulsenmore's continued momentum in the U.S. market following its recent FDA clearance and initial commercial engagement. The partnership with TLC Perinatal PA, a specialized maternal-fetal medicine practice, demonstrates increasing adoption of Pulsenmore's home ultrasound technology. This expansion is crucial for the company's growth strategy, validating its patient-centric approach and extending prenatal care access through a hybrid care pathway. Investors should view this as a positive step in the company's U.S. rollout, indicating successful execution and market penetration.